216 related articles for article (PubMed ID: 37024900)
1. The efficacy and safety of high-dose nonsedating antihistamines in chronic spontaneous urticaria: a systematic review and meta-analysis of randomized clinical trials.
Xiao X; Xue P; Shi Y; Yao J; Cao W; Zhang L; Zou Z; Zhou S; Wang C; Chen M; Jin R; Li Y; Zheng Q
BMC Pharmacol Toxicol; 2023 Apr; 24(1):23. PubMed ID: 37024900
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Comparative Efficacy and Acceptability of Licensed Dose Second-Generation Antihistamines in Chronic Spontaneous Urticaria: A Network Meta-Analysis.
Phinyo P; Koompawichit P; Nochaiwong S; Tovanabutra N; Chiewchanvit S; Chuamanochan M
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):956-970.e57. PubMed ID: 32916325
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Intensive Nonsedating Antihistamines for Chronic Spontaneous Urticaria: A Meta-Analysis of Randomized Controlled Trials.
Zhou P; Zeng S; Fu L; Chen H; Li L
Int Arch Allergy Immunol; 2022; 183(7):796-803. PubMed ID: 35144258
[TBL] [Abstract][Full Text] [Related]
5. Comparative Safety Profiles of Individual Second-Generation H1-Antihistamines for the Treatment of Chronic Urticaria: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Chaichan W; Ruengorn C; Thavorn K; Hutton B; Szepietowski JC; Bernstein JA; Chuamanochan M; Nochaiwong S
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2365-2381. PubMed ID: 37088368
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria.
Ayse Ornek S; Orcen C; Church MK; Kocaturk E
Int Immunopharmacol; 2022 Nov; 112():109198. PubMed ID: 36115277
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Up-dosing Antihistamines in Chronic Spontaneous Urticaria: A Systematic Review of the Literature.
Iriarte Sotés P; Armisén M; Usero-Bárcena T; Rodriguez Fernández A; Otero Rivas MM; Gonzalez MT; Meijide Calderón A; Veleiro B;
J Investig Allergol Clin Immunol; 2021 Jul; 31(4):282-291. PubMed ID: 33030434
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
Fukunaga A; Oda Y; Washio K; Omori T; Kakei Y; Hide M; Nishigori C
Trials; 2020 Jan; 21(1):23. PubMed ID: 31906999
[TBL] [Abstract][Full Text] [Related]
9. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis.
Guillén-Aguinaga S; Jáuregui Presa I; Aguinaga-Ontoso E; Guillén-Grima F; Ferrer M
Br J Dermatol; 2016 Dec; 175(6):1153-1165. PubMed ID: 27237730
[TBL] [Abstract][Full Text] [Related]
10. Delayed Pressure Urticaria: A Systematic Review of Treatment Options.
Kulthanan K; Ungprasert P; Tuchinda P; Chularojanamontri L; Charoenpipatsin N; Maurer M
J Allergy Clin Immunol Pract; 2020 Jun; 8(6):2035-2049.e5. PubMed ID: 32179196
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Bilastine on Symptoms of Allergic Rhinitis and Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Abdelshafy AM; Abdallah SY; Hassan AF; Mohamed HA; Kamal NM; Ali ST; Abdelhaleem IA
Am J Rhinol Allergy; 2022 Sep; 36(5):684-694. PubMed ID: 35593100
[TBL] [Abstract][Full Text] [Related]
12. Comparing four immunosuppressive agents for chronic spontaneous urticaria-A network meta-analysis.
Bei W; Qian J; Zilu Q; Kai C; Ruili J; Feng H; Liuqing C
Int Immunopharmacol; 2023 Oct; 123():110577. PubMed ID: 37567010
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments.
Mitchell S; Balp MM; Samuel M; McBride D; Maurer M
Int J Dermatol; 2015 Sep; 54(9):1088-104. PubMed ID: 25515967
[TBL] [Abstract][Full Text] [Related]
14. Compound glycyrrhizin combined with antihistamines for chronic urticaria: A protocol for systematic review and meta analysis.
Cao W; Xiao X; Zhang L; Liu Y; Wang L; Zou Z; Cao Y; Li C; Zheng Q; Zhou S; Li Y
Medicine (Baltimore); 2020 Aug; 99(33):e21624. PubMed ID: 32872021
[TBL] [Abstract][Full Text] [Related]
15. Cardiac safety of second-generation H
Cataldi M; Maurer M; Taglialatela M; Church MK
Clin Exp Allergy; 2019 Dec; 49(12):1615-1623. PubMed ID: 31519068
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Pharmacologic Treatments for H1 Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Network Meta-analysis.
Nochaiwong S; Chuamanochan M; Ruengorn C; Awiphan R; Tovanabutra N; Chiewchanvit S
JAMA Dermatol; 2021 Nov; 157(11):1316-1327. PubMed ID: 34431983
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of uncontrolled symptoms using the standard dose of second-generation H1 -antihistamines in chronic spontaneous urticaria children.
Koosakulchai V; Yuenyongviwat A; Sangsupawanich P
Asian Pac J Allergy Immunol; 2022 Jun; 40(2):121-125. PubMed ID: 32061244
[TBL] [Abstract][Full Text] [Related]
18. Treatments of cold urticaria: A systematic review.
Kulthanan K; Hunnangkul S; Tuchinda P; Chularojanamontri L; Weerasubpong P; Subchookul C; Maurer M
J Allergy Clin Immunol; 2019 Apr; 143(4):1311-1331. PubMed ID: 30776418
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of Runzao Zhiyang capsule for chronic urticaria: a systematic review and meta-analysis of randomized controlled trials.
Zhang JF; Wang YD; Lin P; Li JC; Guo CQ; Zhai JB; Zhang Y
Front Pharmacol; 2023; 14():1200252. PubMed ID: 37693898
[No Abstract] [Full Text] [Related]
20. Comparison between chronic spontaneous urticaria and chronic induced urticaria on the efficacy of omalizumab treatment: A systematic review and meta-analysis.
He ZH; Qiu SC; Huang ZW; Zhang GQ; An QQ; Qu F; Wang N
Dermatol Ther; 2022 Dec; 35(12):e15928. PubMed ID: 36222320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
